Screening newborns for a rare condition that causes progressive muscle weakness and providing early treatment can significantly improve mobility in children with the disease – including the ability to walk, a study suggests.
Researchers in Australia have found a majority of newborns with type one spinal muscular atrophy (SMA) who had early access to treatment were able to walk independently or with help two years after diagnosis.
